Inflammatory Disease News and Research

RSS

Study demonstrates new therapeutic targets for inflammation-associated colon cancer

Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine (IRB Barcelona) report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets. The study has been published in the journal EMBO Molecular Medicine.

12 Jul 2018

Scientists pinpoint new therapeutic targets for inflammation-associated colon cancer

Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets

11 Jul 2018

Aspirin desensitization can help alleviate alcohol-induced allergies in patients with AERD

Patients who suffer from Aspirin Exacerbated Respiratory Disease often experience an additional allergic reaction when drinking alcohol, including nasal congestion, wheezing, and a runny nose.

10 Jul 2018

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

A new positron emission tomography imaging method more fully evaluates the extent of rheumatoid arthritis by targeting translocator protein expression in the synovium (joint lining tissue).

10 Jul 2018

Seeing the Unexpected: Regulatory T Cells and Basophils

Dr. Jagadeesh Bayry from INSERM discusses his recent research in the field of immunology, and how T regulatory cells activate, rather than suppress, basophils.

4 Jul 2018

Pelvic exams do not improve physician's ability to diagnose STDs in adolescent female patients

A pelvic exam does not improve a physician's ability to diagnose certain sexually transmitted diseases in adolescent female patients.

3 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Study finds possible link between Type 2 diabetes and common white pigment

In a pilot study by a team of researchers at The University of Texas at Austin, crystalline particles of titanium dioxide -- the most common white pigment in everyday products ranging from paint to candies -- were found in pancreas specimens with Type 2 diabetes, suggesting that exposure to the white pigment is associated with the disease.

20 Jun 2018

Scientists discover new mechanism controlling multiple sclerosis risk

While the DNA sequence remains the same throughout a person's life, the expression of the encoded genes may change with time and contribute to disease development in genetically predisposed individuals.

19 Jun 2018

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Innovative drugs and new European treatment guidelines refine, improve MS therapy

MS is the most common neurological disease in young adults. There are about 2.3 million people worldwide who face a high risk of ever worsening disabilities from this disease.

18 Jun 2018

Study demonstrates increased levels of gum disease in people at risk of rheumatoid arthritis

The results of a study presented at the Annual European Congress of Rheumatology demonstrates increased levels of gum disease, and disease-causing bacteria, in individuals at risk of rheumatoid arthritis.

18 Jun 2018

Pregnancies in women with rheumatoid arthritis linked to premature delivery and low birth weight

The results of a study presented today at the Annual European Congress of Rheumatology demonstrate that pregnancies in women with rheumatoid arthritis are associated with premature delivery and low birth weight.

14 Jun 2018

Combination of NSAIDs and TNF inhibitors linked to reduced radiographic progression in AS patients

Celecoxib combined with TNF inhibitors was associated with the greatest reduction in radiographic progression.

14 Jun 2018

Study: Early, intensive treatment of rheumatoid arthritis has long-term benefits

The results of a 23-year, follow-up study presented today at the Annual European Congress of Rheumatology suggest early, intensive treatment of rheumatoid arthritis has long-term benefits including the normalisation of mortality to levels consistent with the general population.

13 Jun 2018

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

A Trump administration effort to shift family planning funding toward groups that may not provide comprehensive services and away from organizations that provide abortions could cripple other federal efforts to curb an explosion in sexually transmitted diseases, some public health officials fear.

12 Jun 2018

Immune response in RA patients linked to inflammation and joint damage

To diagnose rheumatoid arthritis, antibodies to the amino acid citrulline are commonly measured. A new study from Uppsala University shows that a broad mix of different antibodies in the joints is the dominant factor that can be associated with severe inflammation and joint damage.

12 Jun 2018

Regeneron collaborates with Zoetis to research antibody therapies for animals

Regeneron Pharmaceuticals, Inc. and Zoetis Inc. today announced a five-year collaboration to research the use of Regeneron's monoclonal antibody therapeutics in animals and discover new veterinary treatments.

6 Jun 2018

Syphilis and gonorrhea on the rise in England

Both sexually transmitted infections (STIs), syphilis and gonorrhoea, are on the rise in modern England, staging a comeback from the Victorian era. Over the past one year, there has been a 20 percent rise in the incidence of STIs. The rates of syphilis for example is on a 70 year high last year according to the Public Health England statistics.

6 Jun 2018

Inflammatory Disease News and Research

Study demonstrates new therapeutic targets for inflammation-associated colon cancer

Scientists pinpoint new therapeutic targets for inflammation-associated colon cancer

Aspirin desensitization can help alleviate alcohol-induced allergies in patients with AERD

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

Seeing the Unexpected: Regulatory T Cells and Basophils

Pelvic exams do not improve physician's ability to diagnose STDs in adolescent female patients

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Study finds possible link between Type 2 diabetes and common white pigment

Scientists discover new mechanism controlling multiple sclerosis risk

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Innovative drugs and new European treatment guidelines refine, improve MS therapy

Study demonstrates increased levels of gum disease in people at risk of rheumatoid arthritis

Pregnancies in women with rheumatoid arthritis linked to premature delivery and low birth weight

Combination of NSAIDs and TNF inhibitors linked to reduced radiographic progression in AS patients

Study: Early, intensive treatment of rheumatoid arthritis has long-term benefits

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

Immune response in RA patients linked to inflammation and joint damage

Regeneron collaborates with Zoetis to research antibody therapies for animals

Syphilis and gonorrhea on the rise in England

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News